As of 2026-03-28, the Intrinsic Value of Dyne Therapeutics Inc (DYN) is -13.81 USD. This DYN valuation is based on the model Peter Lynch Fair Value. With the current market price of 17.14 USD, the upside of Dyne Therapeutics Inc is -180.55%.
Based on its market price of 17.14 USD and our intrinsic valuation, Dyne Therapeutics Inc (DYN) is overvalued by 180.55%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -13.81 - -13.81 | -13.81 | -180.55% |
| P/E | (50.31) - (58.38) | (54.68) | -419.0% |
| DDM - Stable | (19.81) - (79.88) | (49.84) | -390.8% |
| DDM - Multi | (3.95) - (13.09) | (6.15) | -135.9% |
| Market Cap (mil) | 2,769.65 |
| Beta | 1.57 |
| Outstanding shares (mil) | 161.59 |
| Enterprise Value (mil) | 2,025.20 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.43% |
| Cost of Debt | 5.00% |
| WACC | 10.10% |